Risk stratification of stage II rectal mucinous adenocarcinoma to predict the benefit of adjuvant chemotherapy following neoadjuvant chemoradiation and surgery

BackgroundThe treatment strategy for stage II rectal mucinous adenocarcinoma (RMA) recommends neoadjuvant chemoradiotherapy (NCR) followed by total mesorectal excision (TME). However, the necessity of adjuvant chemotherapy (AC) remains controversial.Materials and methodsChi-square test was used to a...

全面介紹

書目詳細資料

Principais autores:	Yahang Liang, Hualin Liao, Haoran Shi, Tao Li, Yaxiong Liu, Yuli Yuan, Mingming Li, Aidi Li, Yang Liu, Yao Yao, Taiyuan Li
格式:	Artigo
語言:	Inglês
出版:	Frontiers Media S.A. 2024-03-01
叢編:	Frontiers in Oncology
主題:	neoadjuvant chemoradiation stage II rectal mucinous adenocarcinoma adjuvant chemotherapy nomogram survival
在線閱讀:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1352660/full
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!